MedPath

PDL and Fractional Photothermolysis for Postsurgical Scars

Not Applicable
Conditions
Scar
Interventions
Device: PDL (Pulsed Dye Laser)
Device: Fractional Photothermolysis Laser
Registration Number
NCT03057964
Lead Sponsor
Northwestern University
Brief Summary

This is a two part study to evaluate the efficacy of early combined PDL (pulsed dye laser) and fractional photothermolysis in the cosmetic improvement of post surgical scars.All subjects will be offered at the time of the dermatologic procedure, an option to treat the post surgical scars with early combined PDL and fractional photothermolysis.

Part A is a non-randomized study design and subjects will have the choice of whether or not they will receive treatment. In part B, subjects will be randomized in a 2:1 treatment vs. control design.

The experimental group will have a total of 6 visits: 1 standard of care suture removal visit, 3 treatment visits and 2 follow up visits. The control group will have 3 visits: 1 standard of care suture removal visit and 2 follow up visits.

Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.

This study is a pilot study designed to determine feasibility of this procedure.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
150
Inclusion Criteria
  1. Males or females ≥ 18 years old
  2. Fitzpatrick skin types I-VI
  3. Subjects are in good health as judged by the investigator.
  4. Subjects who have received dermatologic surgery procedure of the trunk or extremities closed with complex primary closure with subcuticular running suture removed at 2-3 weeks.
  5. Subjects applying topical retinoids, must discontinue one week prior to treatment.
  6. Subjects who are willing and have the ability to understand and provide informed consent for participation in the study and are able to communicate with the investigator.
Read More
Exclusion Criteria
  1. History of recurrent facial or labial herpes simplex infection
  2. Subjects applying topical retinoids, must discontinue one week prior to treatment.
  3. Subjects with a history of hypertrophic scars or keloids
  4. Pregnant or breast feeding
  5. Uncooperative patients or patients with neurological disorders who are incapable of following directions or who are predictably unwilling to return for follow-up examinations.
  6. Subjects who are unable to understand the protocol or give informed consent.
  7. Subjects who in the opinion of the investigator are likely to have exaggerated scarring with laser treatments.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PDL (Pulsed Dye Laser) and Fractional PhotothermolysisPDL (Pulsed Dye Laser)-
PDL (Pulsed Dye Laser) and Fractional PhotothermolysisFractional Photothermolysis Laser-
Primary Outcome Measures
NameTimeMethod
Change in score of Patient and Observer Scar Assessment Scale (POSAS)Baseline and 6 Months

The POSAS is a series of questions about the scar with a scale from 1 to 10 with 1 as "not at all" or "normal skin" and 10 as "very much so" or "very different".

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Northwestern University Feinberg School of Medicine, Department of Dermatology

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath